News
6hon MSN
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...
Pharmaceutical Technology on MSN21h
Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention"Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention" was originally created and published by ...
LoveBScott on MSN22h
PrEP Side Effects: Separating Fact from FictionHIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally ...
As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...
Woodland The Daily Democrat on MSN21h
Lenacapavir approved by FDA: What it means for HIV preventionThe Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
The Supreme Court on Friday rejected a challenge to the structure of a Department of Health and Human Services task force ...
The Supreme Court on Friday upheld the constitutionality of an ObamaCare requirement that insurance companies cover certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback